drugset / Trial / NCT01657071
Comparative Pharmacokinetics of YH14659 in Healthy Male Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
The objective of this study is to compare pharmacokinetics after single oral administration of 2 capsules of YH14659, a fixed-dose combination of clopidogrel and aspirin developed by Yuhan Corporation versus co-administration of Plavix (clopidogrel) and Astrix (aspirin) in healthy male volunteers.
Timeline
- Start
- 2012-03
- Primary completion
- 2012-04
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | 100 mg | Oral |
| Comparator | Clopidogrel | Small molecule | 75 mg | Oral |
| Subject | YH14659 | Unknown | — | Oral |